Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives

E-ISSN： 1873-4316|15|9|829-838

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.9, 2014-09, pp. : 829-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing Lum Peggy Chen Alin Arends Rosalin Roskos Lorin Smith Brian Ruixo Juan José Pérez

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Effects of Nanoscale Confinement on the Functionality of Nucleic Acids: Implications for Nanomedicine

Current Medicinal Chemistry, Vol. 20, Iss. 28, 2013-09 ,pp. : 3539-3557

Bentham Science Publishers

Access to resources Recommend Favorite

Bayesian Calibration of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Carbaryl Cholinesterase Inhibition

By Nong Andy Tan Yu-Mei Krolski Michael Wang Jiansuo Lunchick Curt Conolly Rory Clewell Harvey

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 20, 2008-01 ,pp. : 1363-1381

Taylor & Francis Ltd

Access to resources Recommend Favorite

Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment

By Harrold John Abraham Anson

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 141-151

Springer Publishing Company

Access to resources Recommend Favorite

Chemical modifications of nucleic acids for RNA-based therapeutics

By Grünweller Arnold Hartmann Roland K.

PHARMAKON, Vol. 3, Iss. 4, 2015-07 ,pp. : 263-270

Govi-Verlag

Access to resources Recommend Favorite